Loading clinical trials...
Loading clinical trials...
We assessed the effect of structured nano-water in the prevention of recurrent stone formation in patients with recurrent calcium oxalate stones and hypercalciuria.
The majority of stones (85%) contain primarily calcium oxalate. Most renal stones are idiopathic calcium stones, and the most common predisposing factor in these patients is hypercalciuria. Structured nano-water is a new type of water that has been prepared using different types of energy fields electromagnetic fields to produce this structured nano- water that has new and different characteristics from the ordinary water. In this study, we compared the efficacy of the nano- water with hydrochlorothiazide and with ordinary bottled drinking water in the prevention of recurrent renal stones in patients with idiopathic hypercalciuria. We conducted a three-year randomized trial comparing the effect of structured water with the effect of hydrochlorothiazide and ordinary bottled water in 325 patients with recurrent calcium oxalate stones and hypercalciuria. The patients were randomly divided into three groups. Group A included 108 patients who used structured nano-water in a dose of 20 mL/kg as a daily dose. Group B of 107 patients used 50 mg hydrochlorothiazide tablets as a daily dose, and group C consisted of another 110 patients used ordinary drinking bottled water in a daily dose of 20 mL/kg . The assessments were done by urine analysis with renal ultrasonography and radiology ( Kidney Ureter Bladder KUB X-rays) were done at baseline, at yearly intervals, also at any time of recurrence, and at the end of the 3 years (36th month). The patients, care providers, and the investigators were blinded about the type of water used since the water bottles were unlabeled when given to the patients. All patients were informed and signed a written informed consent form.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
College of Medicine, University of Suliamani
Sulaymaniyah, Kurdistan Region, Iraq
Start Date
February 16, 2015
Primary Completion Date
August 24, 2020
Completion Date
August 24, 2020
Last Updated
November 8, 2024
325
ACTUAL participants
structured nano-water
DIETARY_SUPPLEMENT
Hydrochlorothiazide (HCTZ)
DRUG
ordinary bottled drinking water
OTHER
Lead Sponsor
ALI KAMAL M. SAMI
NCT07155005
NCT07101809
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions